NCT00189553 Caelyx Plus Carboplatin Versus Paclitaxel Plus Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse Status COMPLETED Phase PHASE3
NCT00183924 Estramustine, Docetaxel, and Carboplatin for Patients With Hormone Refractory Prostate Cancer Progressing After Mitoxantrone-Based Chemotherapy. Status COMPLETED Phase PHASE2
NCT00182793 Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer Status COMPLETED Phase PHASE2
NCT00181701 Intraperitoneal Paclitaxel and Carboplatin in the Treatment of Women With Carcinoma of Mullerian Origin Status COMPLETED Phase PHASE2
NCT00179920 Chemotherapy Treatment for Children With Intraocular Germ-Line Retinoblastoma Status COMPLETED Phase PHASE2
NCT00179881 Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma Status COMPLETED Phase PHASE2
NCT00176267 Paclitaxel, Carboplatin And Low Dose Radiation As Induction Therapy In Locally Advanced Head And Neck Cancer Status COMPLETED Phase PHASE2
NCT00176254 Paclitaxel, Carboplatin and Radiotherapy as Induction Therapy in Locally Advanced Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00174356 PH 1 Evaluation Of Oral CI-1033 In Combination With Paclitaxel/ Carboplatin As 1st Line Chemotherapy In NSCLC Patients Status COMPLETED Phase PHASE1
NCT00170664 Taxol/ Carboplatin as First Line Therapy in Patients With Epithelial Ovarian Cancer Status COMPLETED Phase PHASE2
NCT00165139 Intensive Chemo-Radiotherapy With Peripheral Blood Progenitor Cell Rescue for Children With Advanced Neuroblastoma and Sarcomas Status COMPLETED Phase PHASE2
NCT00161278 Pilot Study for the Determination of Tumor Response to Chemotherapy in Advanced NSCLC Through Gene Expression Profiling Status TERMINATED Phase PHASE2
NCT00152477 A Study of Paclitaxel/Carboplatin With or Without CDP791 in Patients With Lung Cancer Status COMPLETED Phase PHASE2
NCT00151034 Trastuzumab (Herceptin), Paclitaxel, Carboplatin and Gemcitabine in Advanced Urothelial Cancer Status COMPLETED Phase PHASE2
NCT00150657 Study of Carboplatin/Gemcitabine Plus Bevacizumab in Advanced Lung Cancer Status UNKNOWN Phase PHASE2
NCT00148668 Preoperative Herceptin/Navelbine Versus Taxotere/Carboplatin/Herceptin in HER-2 Positive Breast Cancer Status COMPLETED Phase PHASE2
NCT00148395 Randomized Phase III-Study in Stage IIIb and IV Non-Small-Cell Lung Cancer. Sequential Single-Agent vs. Double-Agent vs. Triple-Agent Therapy. Status COMPLETED Phase PHASE3
NCT00148135 Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary Site Status TERMINATED Phase PHASE2
NCT00147537 Combination Study Of CP-751,871 With Paclitaxel And Carboplatin In Advanced Lung Cancer Status COMPLETED Phase PHASE1/PHASE2